TOLNAFTATE ANTIFUNGAL- tolnaftate powder 
Geri-Care Pharmaceuticals, Corp

----------

GC TOLNAFTATE

Active ingredient

Tolnaftate 1%

PURPOSE

ANTIFUNGAL

USES

• for effective treatment of most athlete’s foot (tinea pedis)

and ringworm (tinea corporis)
• for effective relief of itchy, scaly skin between the toes
• clears up most athlete’s foot infection and with daily
use helps keep it from coming back

WARNINGS

For external use only
Do not use on children under 2 years of age unless
directed by a doctor.
When using this product avoid contact with the eyes
Stop use and consult a doctor if
• irritation occurs
• there is no improvement within 4 weeks

KEEP OUT OF REACH OF CHILDREN

If swallowed, get medical help or contact a Poison Control
Center right away.

DIRECTIONS

• shake well before use

• clean the affected area and dry thoroughly
• apply a thin layer of the product over affected area
twice daily (morning and night) or as directed by a doctor
• supervise children in the use of this product
• use daily for 4 weeks. If condition persists longer,
consult a doctor.

For athlete's foot

• pay special attention to the spaces between the toes
• wear well-fitting ventilated shoes
• change shoes and socks at least once daily
• to prevent athlete’s foot, clean and dry feet thoroughly.
Apply as above once or twice daily.
This product is not effective on the scalp or nails.

Other Information

• store at room temperature

INACTIVE INGREDIENTS

corn starch and talc

PACKAGE LABEL

1

TOLNAFTATE ANTIFUNGAL 
tolnaftate powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57896-199
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TOLNAFTATE (UNII: 06KB629TKV) (TOLNAFTATE - UNII:06KB629TKV) TOLNAFTATE1 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
STARCH, CORN (UNII: O8232NY3SJ)  
TALC (UNII: 7SEV7J4R1U)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57896-199-4545 g in 1 BOTTLE, DISPENSING; Type 7: Separate Products Requiring Cross Labeling08/01/2011
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00508/01/2011
Labeler - Geri-Care Pharmaceuticals, Corp (611196254)
Registrant - GCP Laboratories (965480861)
Establishment
NameAddressID/FEIBusiness Operations
GCP Laboratories965480861manufacture(57896-199)

Revised: 11/2023
Document Id: 09a769e6-0aed-0a17-e063-6394a90a85d6
Set id: f9e60430-eec1-4bc2-9522-eb5aa527d90a
Version: 4
Effective Time: 20231108
 
Geri-Care Pharmaceuticals, Corp